Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of TAS-102 in Previously Treated Unresectable or Metastatic Squamous Cell Carcinoma of the Lung

NCT02920476 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT02920476
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02920476 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of TAS-102 in Previously Treated Unresectable or Metastatic Squamous Cell Carcinoma of the Lung
Lead sponsor
University of Florida
Phase
Phase 2
Overall status
Completed
Start date
July 19, 2017
Completion date
August 14, 2021
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

squamous cell lung carcinoma